Bacteroides infectious disease

Summary

Bacteroides infectious disease (MONDO:0006671) is a disease. A subtype of Bacteroidaceae infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	Bacteroides infectious disease
Mondo ID	MONDO:0006671
EFO	EFO:1000832
MeSH	D001442
SNOMED CT	2918000
UMLS	C0004669
MedGen	2164
Is cancer (heuristic)	no

Also known as: Bacteroides caused disease or disorder · Bacteroides disease or disorder · Bacteroides infection · infection due to Bacteroides · infection, Bacteroides · infections, Bacteroides

Disease family

This is a subtype of Bacteroidaceae infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › bacterial infectious disease › gram-negative bacterial infections › Bacteroidaceae infectious disease › Bacteroides infectious disease

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.